# Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis（ECHO-TAVR）

> **NCT07317804** · PHASE4 · NOT_YET_RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 212 (estimated)

## Conditions studied

- Aortic Stenosis
- TAVI
- TAVI(Transcatheter Aortic Valve Implantation)

## Interventions

- **DEVICE:** Echocardiographic guidance
- **DEVICE:** Fluoroscopic guidance

## Key facts

- **NCT ID:** NCT07317804
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-26
- **Primary completion:** 2028-07-30
- **Final completion:** 2028-07-31
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07317804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07317804, "Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis（ECHO-TAVR）". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07317804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*